1. 1851 Safety analysis, correlation with response and previous treatments of the association of everolimus (EVE) and exemestane (EXE) in 181 metastatic breast cancer patients (MBC). (September 2015) Authors: Moscetti, L.; Vici, P.; Sperduti, I.; Fabbri, M.A.; Natoli, C.; Mancini, M.L.; Sini, V.; D'Onofrio, L.; Pizzuti, L.; Vaccaro, A.; Magnolfi, E.; Magri, V.; Trenta, P.; Ramponi, S.; Roma, C.; Ruggeri, E.M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1861 Body mass index and prognosis in HER2-positive metastatic breast cancer patients. (September 2015) Authors: Poletto, E.; Minisini, A.M.; Ferreira, A.; Matteo, L.; Poggio, F.; Sottotetti, F.; Montemurro, F.; Pozzi, E.; Rossi, V.; Risi, E.; Dellepiane, C.; Sini, V.; Ziliani, S.; Minuti, G.; Mura, S.; Grasso, D.; Bertolini, I.; Del Mastro, L.; Puglisi, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1863 First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (neo)adjuvant trastuzumab. (September 2015) Authors: Vaglica, M.; Lambertini, M.; Ferreira, A.; Poggio, F.; Puglisi, F.; Sottotetti, F.; Montemurro, F.; Poletto, E.; Pozzi, E.; Risi, E.; Lai, A.; Zanardi, E.; Sini, V.; Ziliani, S.; Minuti, G.; Mura, S.; Grasso, D.; Ferrarini, I.; Pronzato, P.; Del Mastro, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1950 Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study. (September 2015) Authors: Gamucci, T.; Mentuccia, L.; Vici, P.; Iezzi, L.; Sperduti, I.; Astone, A.; Marchetti, P.; Pizzuti, L.; Michelotti, A.; Sini, V.; Cassano, A.; Ciancola, F.; Quadrini, S.; Moscetti, L.; Landucci, E.; Sergi, D.; Magnolfi, E.; Natoli, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A12First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (NEO)adjuvant trastuzumab. (26th September 2015) Authors: Vaglica, M.; Vaglica, M.; Lambertini, M.; Ferreira, A.; Poggio, F.; Puglisi, F.; Sottotetti, F.; Montemurro, F.; Poletto, E.; Pozzi, E.; Risi, E.; Lai, A.; Zanardi, E.; Sini, V.; Ziliani, S.; Minuti, G.; Mura, S.; Grasso, D.; Ferrarini, I.; Pronzato, P. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 6 Page Start: vi6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience. (October 2016) Authors: Moscetti, L.; Vici, P.; Gamucci, T.; Natoli, C.; Cortesi, E.; Marchetti, P.; Santini, D.; Giuliani, R.; Sperduti, I.; Mauri, M.; Pizzuti, L.; Mancini, M.L.; Fabbri, M.A.; Magri, V.; Iezzi, L.; Sini, V.; D'Onofrio, L.; Mentuccia, L.; Vaccaro, A.; Ramponi, S. Journal: Breast Issue: Volume 29(2016) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗